An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia
Open Access
- 3 October 2013
- journal article
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 379
Abstract
Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality in all age groups worldwide. It may be classified as mild/moderate or severe, the latter usually requiring hospitalisation. Although, there are many studies reported in relation to CAP, there is relatively little known about the treatment of CAP and its antibiotic use in Mongolia. The study aim was to evaluate prescribing practices for the treatment of mild/moderate CAP in Mongolia with respect to national prescribing guidelines.Keywords
This publication has 36 references indexed in Scilit:
- Behavior Change Strategies to Influence Antimicrobial Prescribing in Acute Care: A Systematic ReviewClinical Infectious Diseases, 2011
- Combating inappropriate use of medicinesExpert Review of Clinical Pharmacology, 2011
- Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes2010
- Dealing with childhood pneumonia in developing countries: how can we make a difference?Archives of Disease in Childhood, 2007
- What's new in antibiotic resistance? Focus on beta-lactamasesDrug Resistance Updates, 2006
- Rapid assessment of injection practices in MongoliaAmerican Journal of Infection Control, 2004
- Prospective Study of Prognostic Factors in Community‐Acquired Bacteremic Pneumococcal Disease in 5 CountriesThe Journal of Infectious Diseases, 2000
- Un estudio de minimización de costes en la prescripción de antiinfecciosos en dos areas de atención primariaRevista Espanola de Salud Publica, 1998
- Cost-Effectiveness Opportunities for New AntibioticsPharmacoEconomics, 1994
- Estimating Worldwide Current Antibiotic Usage: Report of Task Force 1Clinical Infectious Diseases, 1987